ELIXF (Elixxer) OCF Margin %: 0.00% (As of Dec. 2025)


What is Elixxer OCF Margin %?

Elixxer ELIXF OCF Margin % is 0.00% as of Dec. 2025. The stock has 1 warning sign investors should review. Among 959 Drug Manufacturers companies, Elixxer ranks worse than 104275.18% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Elixxer's Cash Flow from Operations for the three months ended in Dec. 2025 was $-0.19 Mil. Elixxer's Revenue for the three months ended in Dec. 2025 was $0.00 Mil. Therefore, Elixxer's OCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Elixxer's current OCF Yield % is -21.15%.

The historical rank and industry rank for Elixxer's OCF Margin % or its related term are showing as below:


During the past 13 years, the highest OCF Margin % of Elixxer was -2661.27%. The lowest was -18831.25%. And the median was -9791.67%.

ELIXF's OCF Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 9.94
* Ranked among companies with meaningful OCF Margin % only.

Elixxer OCF Margin % Related Terms

Elixxer OCF Margin % Historical Data

* Premium members only.

The historical data trend for Elixxer's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elixxer OCF Margin % Chart

Elixxer Annual Data
Trend Jun15 Jun16 Sep17 Sep18 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Elixxer Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Elixxer OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Elixxer's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-0.511/0
= %

Elixxer's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-0.191/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Elixxer (ELIXF) has a OCF Margin % of 0.00% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Elixxer and its competitors. According to the industry distribution chart, Elixxer ranks #999999 out of 959 companies in the Drug Manufacturers industry.
Is Elixxer's OCF Margin % too high?
Elixxer's current OCF Margin % is 0.00%. Based on the distribution chart, Elixxer ranks #999999 out of 959 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Elixxer's OCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Elixxer ranks #999999 out of 959 companies for OCF Margin %. This places Elixxer in the lower half of its industry. The industry median OCF Margin % is 9.94. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.94, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Elixxer and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Elixxer's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elixxer stock overvalued right now?
Elixxer (ELIXF) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Elixxer (ELIXF), the current OCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Elixxer Business Description

Other Exchanges ELXR.H:Canada
Address 200 Bay Street, Suite 3240, Royal Bank Plaza, South Tower, Toronto, ON, CAN, M5J 2J1
Elixxer Ltd is a Canada-based cannabis investment firm in the legal cannabis market. It invests in cannabis-related businesses that are fully licensed for the cultivation, production, and sale of cannabis and cannabis-derived products.